INT68250

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.40
First Reported 1997
Last Reported 2010
Negated 2
Speculated 0
Reported most in Body
Documents 7
Total Number 7
Disease Relevance 2.99
Pain Relevance 1.56

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Ighg1)
Anatomy Link Frequency
Th2 cells 2
PSP 2
Ighg1 (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 91 100.00 Very High Very High Very High
Inflammation 77 100.00 Very High Very High Very High
chemokine 9 100.00 Very High Very High Very High
Enkephalin 7 99.92 Very High Very High Very High
methotrexate 5 90.60 High High
dexamethasone 5 90.40 High High
Arthritis 1 89.60 High High
Inflammatory response 1 69.28 Quite High
cINOD 1 69.24 Quite High
rheumatoid arthritis 1 66.16 Quite High
Disease Link Frequency Relevance Heat
INFLAMMATION 80 100.00 Very High Very High Very High
Hypersensitivity 58 100.00 Very High Very High Very High
Sprains And Strains 92 98.28 Very High Very High Very High
Arthritis 4 89.60 High High
Cancer 71 84.92 Quite High
Apoptosis 1 81.72 Quite High
Lewis Lung Carcinoma 136 77.92 Quite High
Asthma 46 70.32 Quite High
Rheumatoid Arthritis 1 66.16 Quite High
Anaphylaxis 12 59.84 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
IgG1 production was unaffected by MENK.
Neg (unaffected) Regulation (unaffected) of Gene_expression (production) of IgG1 associated with enkephalin
1) Confidence 0.40 Published 1997 Journal J. Neuroimmunol. Section Abstract Doc Link 9058757 Disease Relevance 0 Pain Relevance 0.45
D-PA failed to influence anti-OVA IgG, IgG2a and IgG1 production as well as IFN-gamma and IL-10 secretion.
Neg (failed) Regulation (influence) of Gene_expression (production) of IgG1
2) Confidence 0.38 Published 2005 Journal Int J Immunopathol Pharmacol Section Abstract Doc Link 15698518 Disease Relevance 0.58 Pain Relevance 0.58
g OVA, regardless of PSP dose, induced significantly higher IgE levels than the other OVA doses, and higher IgG1 levels than 100 ?
Regulation (regardless) of Gene_expression (levels) of IgG1 in PSP
3) Confidence 0.34 Published 2005 Journal BMC Immunol Section Body Doc Link PMC1182367 Disease Relevance 0.18 Pain Relevance 0.03
ELISA for detection of IgE, IgG1 and IgG2a anti-OVA antibodies
Regulation (ELISA) of Gene_expression (detection) of IgG1
4) Confidence 0.34 Published 2005 Journal BMC Immunol Section Body Doc Link PMC1182367 Disease Relevance 0.24 Pain Relevance 0.04
Serum levels of OVA-specific IgG1 and IgG2a
Regulation (specific) of Gene_expression (levels) of IgG1
5) Confidence 0.30 Published 2010 Journal Allergy, Asthma & Immunology Research Section Body Doc Link PMC2892053 Disease Relevance 0 Pain Relevance 0
, and control the production of IgG2a, whereas Th2 cells produce IL-4, IL-5, and IL-10, and control the production of IgG1 and IgE.
Regulation (control) of Gene_expression (production) of IgG1 in Th2 cells
6) Confidence 0.17 Published 2007 Journal Journal of Korean Medical Science Section Body Doc Link PMC2694397 Disease Relevance 1.06 Pain Relevance 0.12
The aim of the present study was to elucidate the effects of two sizes of carbon nano particles (14 nm or 56 nm) on allergic airway inflammation, local expression of cytokines, chemokines, and 8-hydroxy-2'-deoxyguanosine (8-OHdG), and production of total IgE and antigen-specific IgG1, IgG2a, and IgE.


Regulation (effects) of Gene_expression (production) of IgG1 associated with chemokine, inflammation, hypersensitivity and cytokine
7) Confidence 0.15 Published 2005 Journal Respir Res Section Body Doc Link PMC1242256 Disease Relevance 0.92 Pain Relevance 0.34

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox